• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/15

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

15 Cards in this Set

  • Front
  • Back
when is xrt therapy required after mastectomy?
Tumors greater than 5 cm
Positive surgical margins
4 or more positive axillary lymph nodes
when do you use CMF in BC?
in low risk or intermed risk
node neg disease only
>1 cm
when do you use antracycline countaining regimen in BC?
node+ w/wo taxane

High risk N- disease HER2+ ER-
taxane containing regimens in BC?
node-positive disease
Triple neg BC
benefit from neoadv
a+-taxane in lymph node +
followed by surgery
management of operational III BC
just large tumor N1

surgery +- radio
stage III a,b,c bc tx

no response?
neoadv chemo
if response then local therapy
- may be surgery
- RADIO and Remove axillary nodes

no response= chemo considered, neo adv surgery
T4c inflammatory BC bc
clinical trials
ex: ER- HER2 +
consider neoadv taxane
when do you use fulvestrant?
when tamoifen has failed inrecurrnace
after stable disease after amoratase inhib
mammogram screening specificity
number of patients with a negative test who do not have the disease/number of patients who do not have the disease
mammogram screening sensivity
Patients with a positive mammogram/all patients screened with a mammogram who have breast cancer
most important prognostic factor in BC?
axillary lymph node status
chemo in ovarian cancer?
taxane and cispaltin
type I uterine tumor
adenocarcinoma
low grade
stim by estrogen
type II uterine tumor
papillary or clear cell
high grade
unrelated to estrogen
more aggressive!